Nirmatrelvir with Ritonavir - Covid-19
You are here : Home > Formulary Search > Nirmatrelvir with Ritonavir - Covid-19
Status 1
- Tablets
Primary care and outpatient prescribing of antivirals for COVID 19 treatment is through the CMDU service.
Hospital inpatients - as per local hospital guidelines.
Documentation
PAD Profile
Other Indications
Below are listed other indications that Nirmatrelvir with Ritonavir is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Covid-19.
Committee Recommendations (2)
The Surrey Heartland Integrated Care System Area Prescribing Committee agree implementation of NICE TA878 Casirivimab plus imdevimab, nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19.
Nirmatrelvir with ritonavir *(Paxlovid) is agreed as RED for prescription only by the commissioned CMDU service (not for prescribing through A&E / hospital clinics)
*if a patient who falls into one of the highest risk cohorts is in hospital and gets COVID-19 (not admitted due to COVID) then these individuals should be treated with Paxlovid / Sotrovimab in line with NICE TA878 whilst they are an inpatient.
Patients eligible for treatment with Covid antiviral medicines will be able to obtain a supply from one of our locally designated Community Pharmacies. Prescriptions will be sent via the Electronic Prescription Service (EPS) to one of the designated pharmacies.
A list of these pharmacies can be found in the document "CMDU Community Pharmacies" (updated June 2025)
The Surrey Heartland Integrated Care System Area Prescribing Committee agree implementation of NICE TA878 Casirivimab plus imdevimab, nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19.
Nirmatrelvir with ritonavir *(Paxlovid) is agreed as RED for prescription only by the commissioned CMDU service (not for prescribing through A&E / hospital clinics)
*if a patient who falls into one of the high risk cohorts is in hospital and gets COVID-19 (not admitted due to COVID) then these individuals should be treated with Paxlovid / Sotrovimab in line with NICE TA878 whilst they are an inpatient.